drugset / Trial / NCT03476746
Dermatopharmacokinetic Trial of LEO 90100 Foam
RandomizedSingle-groupOpen-labelOther
Summary
This is a phase 1, single centre trial in Japanese healthy male subjects comparing the amount of active ingredients of LEO 90100 foam and Dovobet® ointment in the stratum corneum.
Timeline
- Start
- 2018-03-20
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriol | Small molecule | 50 unknown | — |
| Subject | betamethasone dipropionate | Small molecule | 0.643 unknown | — |
Indications
No indication recorded.